A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression

Fluoxetine is the first selective serotonin reuptake inhibitor antidepressant to he marketed in the U.S. In this double-blind trial fluoxetine was compared with imipramine and placebo among 198 outpatients with DSM-III major depression, of, whom 145 completed at least 2 weeks of active treatment and...

Ausführliche Beschreibung